Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Fatty acid activates NLRP3 inflammasomes in mouse Kupffer cells through mitochondrial DNA release
Junjiang Pan, Zhi-bing Ou, Can Cai, et al.
Cellular Immunology (2018) Vol. 332, pp. 111-120
Closed Access | Times Cited: 104

Showing 1-25 of 104 citing articles:

Hepatic macrophages in liver homeostasis and diseases-diversity, plasticity and therapeutic opportunities
Yankai Wen, Joeri Lambrecht, Cynthia Ju, et al.
Cellular and Molecular Immunology (2020) Vol. 18, Iss. 1, pp. 45-56
Open Access | Times Cited: 465
The effect of palmitic acid on inflammatory response in macrophages: an overview of molecular mechanisms
Jan Korbecki, Karolina Bajdak-Rusinek
Inflammation Research (2019) Vol. 68, Iss. 11, pp. 915-932
Open Access | Times Cited: 368
Pathogenesis of Nonalcoholic Steatohepatitis: An Overview
Gopanandan Parthasarathy, Xavier S. Revelo, Harmeet Malhi
Hepatology Communications (2020) Vol. 4, Iss. 4, pp. 478-492
Open Access | Times Cited: 344
Immune mechanisms linking metabolic injury to inflammation and fibrosis in fatty liver disease – novel insights into cellular communication circuits
Moritz Peiseler, Robert F. Schwabe, Jochen Hampe, et al.
Journal of Hepatology (2022) Vol. 77, Iss. 4, pp. 1136-1160
Open Access | Times Cited: 287
Targeted therapeutics and novel signaling pathways in non-alcohol-associated fatty liver/steatohepatitis (NAFL/NASH)
Xiaohan Xu, Kyle L. Poulsen, Lijuan Wu, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 191
KIM-1 mediates fatty acid uptake by renal tubular cells to promote progressive diabetic kidney disease
Yutaro Mori, Amrendra K. Ajay, Jae‐Hyung Chang, et al.
Cell Metabolism (2021) Vol. 33, Iss. 5, pp. 1042-1061.e7
Open Access | Times Cited: 179
Role of the Inflammasome in Liver Disease
Marcelle de Carvalho Ribeiro, Gyöngyi Szabó
Annual Review of Pathology Mechanisms of Disease (2021) Vol. 17, Iss. 1, pp. 345-365
Open Access | Times Cited: 176
The Role of Innate Immune Cells in Nonalcoholic Steatohepatitis
Jingjing Cai, Xiao‐Jing Zhang, Hongliang Li
Hepatology (2019) Vol. 70, Iss. 3, pp. 1026-1037
Closed Access | Times Cited: 173
Immunological mechanisms and therapeutic targets of fatty liver diseases
Hua Wang, Wajahat Z. Mehal, Laura E. Nagy, et al.
Cellular and Molecular Immunology (2020) Vol. 18, Iss. 1, pp. 73-91
Open Access | Times Cited: 152
Oxidative Stress Is a Key Modulator in the Development of Nonalcoholic Fatty Liver Disease
Yuanqiang Ma, Gyurim Lee, Suyoung Heo, et al.
Antioxidants (2021) Vol. 11, Iss. 1, pp. 91-91
Open Access | Times Cited: 128
The NLRP3 Inflammasome in Non-Alcoholic Fatty Liver Disease and Steatohepatitis: Therapeutic Targets and Treatment
Lili Yu, Wei Hong, Shen Lu, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 79
Understanding the cellular interactome of non-alcoholic fatty liver disease
Sebastian Wallace, Frank Tacke, Robert F. Schwabe, et al.
JHEP Reports (2022) Vol. 4, Iss. 8, pp. 100524-100524
Open Access | Times Cited: 77
Molecular Mechanism of Lipotoxicity as an Interesting Aspect in the Development of Pathological States—Current View of Knowledge
Katarzyna Lipke, Adriana Kubis-Kubiak, Agnieszka Piwowar
Cells (2022) Vol. 11, Iss. 5, pp. 844-844
Open Access | Times Cited: 70
Liver fibrosis in NAFLD/NASH: from pathophysiology towards diagnostic and therapeutic strategies
Maurizio Parola, Massimo Pinzani
Molecular Aspects of Medicine (2023) Vol. 95, pp. 101231-101231
Open Access | Times Cited: 53
Mitochondrial DNA in liver inflammation and oxidative stress
Xufei Zhang, Xiuwen Wu, Qiongyuan Hu, et al.
Life Sciences (2019) Vol. 236, pp. 116464-116464
Closed Access | Times Cited: 131
Pyroptosis in Liver Disease: New Insights into Disease Mechanisms
Jiali Wu, Su Lin, Bo Wan, et al.
Aging and Disease (2019) Vol. 10, Iss. 5, pp. 1094-1094
Open Access | Times Cited: 129
Apaf-1 Pyroptosome Senses Mitochondrial Permeability Transition
Wanfeng Xu, Yuan Che, Quan Zhang, et al.
Cell Metabolism (2020) Vol. 33, Iss. 2, pp. 424-436.e10
Open Access | Times Cited: 119
Hepatic Macrophages in Liver Injury
Zhao Shan, Cynthia Ju
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 103
Immunopathobiology and therapeutic targets related to cytokines in liver diseases
Yong He, Seonghwan Hwang, Yeni Ait Ahmed, et al.
Cellular and Molecular Immunology (2020) Vol. 18, Iss. 1, pp. 18-37
Open Access | Times Cited: 103
Strategies for Targeting the NLRP3 Inflammasome in the Clinical and Preclinical Space
Adam G. Schwaid, Kerrie B. Spencer
Journal of Medicinal Chemistry (2020) Vol. 64, Iss. 1, pp. 101-122
Closed Access | Times Cited: 101
Role of the NLRP3 Inflammasome in Preeclampsia
Koumei Shirasuna, Tadayoshi Karasawa, Masafumi Takahashi
Frontiers in Endocrinology (2020) Vol. 11
Open Access | Times Cited: 95
The Emerging Role of B Cells in the Pathogenesis of NAFLD
Fanta Barrow, Saad Khan, Haiguang Wang, et al.
Hepatology (2021) Vol. 74, Iss. 4, pp. 2277-2286
Open Access | Times Cited: 78
Mitochondrial dysfunction and liver disease: role, relevance, and potential for therapeutic modulation
Paul Middleton, Nikhil Vergis
Therapeutic Advances in Gastroenterology (2021) Vol. 14
Open Access | Times Cited: 64
Overexpression of NAG-1/GDF15 prevents hepatic steatosis through inhibiting oxidative stress-mediated dsDNA release and AIM2 inflammasome activation
Ying Wang, Chaojie Chen, Jiajun Chen, et al.
Redox Biology (2022) Vol. 52, pp. 102322-102322
Open Access | Times Cited: 64
Mitochondrial DNA in NLRP3 inflammasome activation
Yanbing Qiu, Yumei Huang, Meilin Chen, et al.
International Immunopharmacology (2022) Vol. 108, pp. 108719-108719
Closed Access | Times Cited: 61
Page 1 - Next Page

Scroll to top